Moleculin Biotech, Inc. (MBRX)
Trading
Quantity
Profitability
Ownership
Largest Insider Buys in Sector
MBRX Insider Trading Activity
MBRX Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
Related Transactions
About Moleculin Biotech, Inc.
Moleculin Biotech, Inc., a clinical-stage pharmaceutical company, focuses on the development of drug candidates for the treatment of highly resistant tumors and viruses. Its lead drug candidate is Annamycin that is in Phase 1/2 studies for the treatment of relapsed or refractory acute myeloid leukemia (AML) and cancers metastasized to the lungs. The company's flagship immune/transcription modulator is WP1066, which is in Phase I clinical trial for the treatment of brain tumors and pediatric brain tumors, as well as pancreatic cancer and other …
Insider Activity of Moleculin Biotech, Inc.
Over the last 12 months, insiders at Moleculin Biotech, Inc. have bought $0 and sold $0 worth of Moleculin Biotech, Inc. stock.
On average, over the past 5 years, insiders at Moleculin Biotech, Inc. have bought $175,684 and sold $0 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 188,404 shares for transaction amount of $129,999 was made by KLEMP WALTER V (CEO and President) on 2023‑12‑26.
List of Insider Buy and Sell Transactions, Moleculin Biotech, Inc.
| 2023-12-26 | KLEMP WALTER V | CEO and President | 188,404 0.6709% | $0.69 | $129,999 | -59.21% | ||
| 2023-12-26 | Foster Jonathan P. | Chief Financial Officer | 28,986 0.1032% | $0.69 | $20,000 | -59.21% | ||
| 2023-12-26 | George Robert E. | director | 14,493 0.0516% | $0.69 | $10,000 | -59.21% | ||
| 2022-11-25 | KLEMP WALTER V | CEO and President | 45,000 0.1562% | $1.28 | $57,632 | -49.25% | ||
| 2022-11-21 | KLEMP WALTER V | CEO and President | 22,500 0.0729% | $1.15 | $25,866 | -46.83% | ||
| 2022-11-17 | KLEMP WALTER V | CEO and President | 24,742 0.0849% | $1.02 | $25,257 | -36.28% | ||
| 2022-11-16 | KLEMP WALTER V | CEO and President | 85,213 0.2832% | $0.97 | $82,614 | -34.97% | ||
| 2017-08-16 | Sale | Priebe Waldemar | 10 percent owner | 200,000 0.6259% | $1.70 | $340,600 | -30.57% | |
| 2017-08-16 | Sale | KLEMP WALTER V | Chief Executive Officer | 200,000 0.6259% | $1.70 | $340,600 | -30.57% | |
| 2017-05-11 | KLEMP WALTER V | Chief Executive Officer | 24,000 0.133% | $0.81 | $19,440 | +128.51% | ||
| 2017-05-05 | Northcut Jacqueline | director | 2,000 0.0057% | $0.41 | $820 | +133.75% | ||
| 2017-04-28 | George Robert E. | director | 2,000 0.0058% | $0.47 | $938 | +105.49% | ||
| 2017-04-25 | Foster Jonathan P. | Exec. Vice President & CFO | 20,000 0.1113% | $0.86 | $17,298 | +114.94% |
Insider Historical Profitability
| KLEMP WALTER V | CEO and President | 680880 5.1184% | $789,820.80 | 6 | 1 | <0.0001% |
| Foster Jonathan P. | Chief Financial Officer | 80556 0.6056% | $93,444.96 | 2 | 0 | +27.87% |
| George Robert E. | director | 14660 0.1102% | $17,005.60 | 2 | 0 | +23.14% |
| Northcut Jacqueline | director | 1000 0.0075% | $1,160.00 | 1 | 0 | +133.75% |
Historical Insider Profitability vs. Competitors
$8,900,811 | 57 | -24.79% | $14.9M | |
$85,897,100 | 36 | 2.47% | $16.75M | |
$217,684 | 34 | 1.61% | $17.84M | |
$4,368,362 | 28 | -22.35% | $13.81M | |
$550,893 | 22 | -22.12% | $15.07M |
MBRX Institutional Investors: Active Positions
| Increased Positions | 9 | +45% | 45,286 | +9.83% |
| Decreased Positions | 7 | -35% | 41,199 | -8.95% |
| New Positions | 4 | New | 9,669 | New |
| Sold Out Positions | 2 | Sold Out | 24 | Sold Out |
| Total Postitions | 22 | +10% | 464,651 | +0.89% |
MBRX Ownership Change vs Market
Institutional Investor Ownership
| Armistice Capital, Llc | $410.00 | 2.65% | 317,586 | +27,586 | +9.51% | 2024-12-31 |
| Lpl Financial Llc | $53.00 | 0.34% | 41,215 | +5,112 | +14.16% | 2024-12-31 |
| Vanguard Group Inc | $40.00 | 0.26% | 30,935 | -40,468 | -56.67% | 2024-12-31 |
| Geode Capital Management, Llc | $28.00 | 0.18% | 22,024 | +206 | +0.94% | 2024-12-31 |
| Blackrock, Inc. | $16.00 | 0.1% | 12,380 | -95 | -0.76% | 2024-12-31 |
| Renaissance Technologies Llc | $15.00 | 0.1% | 11,496 | +500 | +4.55% | 2024-12-31 |
| Truist Financial Corp | $14.00 | 0.09% | 10,500 | 0 | 0% | 2024-12-31 |
| Ubs Group Ag | $12.00 | 0.07% | 8,939 | +8,939 | New | 2024-12-31 |
| Tower Research Capital Llc (Trc) | $5.00 | 0.03% | 4,024 | +2,213 | +122.2% | 2024-12-31 |
| Atticus Wealth Management, Llc | $4.00 | 0.02% | 2,784 | -550 | -16.5% | 2024-12-31 |